Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12558625rdf:typepubmed:Citationlld:pubmed
pubmed-article:12558625lifeskim:mentionsumls-concept:C0024301lld:lifeskim
pubmed-article:12558625lifeskim:mentionsumls-concept:C0393022lld:lifeskim
pubmed-article:12558625lifeskim:mentionsumls-concept:C0544452lld:lifeskim
pubmed-article:12558625lifeskim:mentionsumls-concept:C1413947lld:lifeskim
pubmed-article:12558625lifeskim:mentionsumls-concept:C0055598lld:lifeskim
pubmed-article:12558625lifeskim:mentionsumls-concept:C2717829lld:lifeskim
pubmed-article:12558625lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:12558625pubmed:issue1lld:pubmed
pubmed-article:12558625pubmed:dateCreated2003-1-31lld:pubmed
pubmed-article:12558625pubmed:abstractTextWe describe a 50-year-old female patient who developed extensive lymphomatous infiltrates on her forehead, scalp and face within a few months. Histology and immunohistochemistry of skin tumours revealed a CD20 positive follicular B-cell lymphoma. Subsequently, extracutaneous manifestations were detected by computed tomography scans and bone marrow biopsy. The patient suffered from a primary nodular malignant lymphoma with extraordinary cutaneous infiltration of the head. Therefore, combination treatment with a monoclonal antibody against the CD20 antigen, rituximab, and polychemotherapy (CHOP scheme) was administered every 3 weeks. After the second course of treatment a complete regression of cutaneous infiltrates was noticed. Follow-up biopsies on the forehead showed no evidence of CD20 positive lymphoma cells, now. Despite mild leucocytopaenia therapy was well tolerated.lld:pubmed
pubmed-article:12558625pubmed:languageenglld:pubmed
pubmed-article:12558625pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12558625pubmed:citationSubsetIMlld:pubmed
pubmed-article:12558625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12558625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12558625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12558625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12558625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12558625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12558625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12558625pubmed:statusMEDLINElld:pubmed
pubmed-article:12558625pubmed:monthJanlld:pubmed
pubmed-article:12558625pubmed:issn0307-6938lld:pubmed
pubmed-article:12558625pubmed:authorpubmed-author:ChristophersE...lld:pubmed
pubmed-article:12558625pubmed:authorpubmed-author:HauschildAAlld:pubmed
pubmed-article:12558625pubmed:authorpubmed-author:GadóKKlld:pubmed
pubmed-article:12558625pubmed:authorpubmed-author:StockflethEElld:pubmed
pubmed-article:12558625pubmed:authorpubmed-author:SchmookTTlld:pubmed
pubmed-article:12558625pubmed:authorpubmed-author:LischnerStSlld:pubmed
pubmed-article:12558625pubmed:issnTypePrintlld:pubmed
pubmed-article:12558625pubmed:volume28lld:pubmed
pubmed-article:12558625pubmed:ownerNLMlld:pubmed
pubmed-article:12558625pubmed:authorsCompleteYlld:pubmed
pubmed-article:12558625pubmed:pagination31-3lld:pubmed
pubmed-article:12558625pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:meshHeadingpubmed-meshheading:12558625...lld:pubmed
pubmed-article:12558625pubmed:year2003lld:pubmed
pubmed-article:12558625pubmed:articleTitleRemarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP).lld:pubmed
pubmed-article:12558625pubmed:affiliationDepartment of Dermatology, University of Kiel, Germany.lld:pubmed
pubmed-article:12558625pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12558625pubmed:publicationTypeCase Reportslld:pubmed